Toronto University launched a psychedelics center at the university health network (UHN) in partnership with the Nikean Foundation which made a donation of $5 million towards the partnership.
The research center is dubbed ‘Nikean Center for Psychedelic Therapy’ and it aims at becoming a leading academic and innovation hub in the psychedelics space.
The research center will majorly focus on three primary areas namely; research, education and training and clinical care.
When it comes to education and training, the psychedelic research center will aim at delivering a certificate in psychedelic-assisted psychotherapy comprising of apprenticeship, experiential components and didactic.
On matters related to clinical care, the research center is looking forward to start treating patients as psychedelics-assisted therapies are becoming more accessible. Some of them include MDMA-assisted psychotherapy for treating post-traumatic stress disorder (PTSD).
The research center further points out that among its early priorities include treating underserved groups like refugees, LGBTQ and BIOPIC who are currently underrepresented in clinical trials.